| Noninvasive prenatal testing and incidental detection of occult maternal malignancies DW Bianchi, D Chudova, AJ Sehnert, S Bhatt, K Murray, TL Prosen, ... Jama 314 (2), 162-169, 2015 | 450 | 2015 |
| Promises, pitfalls and practicalities of prenatal whole exome sequencing S Best, K Wou, N Vora, IB Van der Veyver, R Wapner, LS Chitty Prenatal diagnosis 38 (1), 10-19, 2018 | 325 | 2018 |
| Discordant noninvasive prenatal testing results in a patient subsequently diagnosed with metastatic disease. CM Osborne, E Hardisty, P Devers, K Kaiser-Rogers, MA Hayden, ... Prenatal diagnosis 33 (6), 609-611, 2013 | 221 | 2013 |
| Prenatal diagnosis: screening and diagnostic tools LM Carlson, NL Vora Obstetrics and Gynecology Clinics 44 (2), 245-256, 2017 | 209 | 2017 |
| Increased death of adipose cells, a path to release cell‐free DNA into systemic circulation of obese women M Haghiac, NL Vora, S Basu, KL Johnson, L Presley, DW Bianchi, ... Obesity 20 (11), 2213-2219, 2012 | 166 | 2012 |
| Prenatal exome sequencing in anomalous fetuses: new opportunities and challenges NL Vora, B Powell, A Brandt, N Strande, E Hardisty, K Gilmore, ... Genetics in Medicine 19 (11), 1207-1216, 2017 | 156 | 2017 |
| Whole exome sequencing: applications in prenatal genetics AC Jelin, N Vora Obstetrics and Gynecology Clinics 45 (1), 69-81, 2018 | 115 | 2018 |
| A multi-factorial relationship exists between total circulating cell-free DNA levels and maternal BMI KL JOHNSON, B Subhabrata, PM CATALANO, ... Prenatal diagnosis 32 (9), 912, 2012 | 95 | 2012 |
| Reproductive issues for adults with autosomal dominant polycystic kidney disease N Vora, R Perrone, DW Bianchi American Journal of Kidney Diseases 51 (2), 307-318, 2008 | 87 | 2008 |
| Increasing the diagnostic yield of exome sequencing by copy number variant analysis DS Marchuk, K Crooks, N Strande, K Kaiser-Rogers, LV Milko, A Brandt, ... PloS one 13 (12), e0209185, 2018 | 78 | 2018 |
| Noninvasive prenatal testing for microdeletion syndromes and expanded trisomies: proceed with caution NL Vora, BM O'Brien Obstetrics & Gynecology 123 (5), 1097-1099, 2014 | 78 | 2014 |
| Genetic considerations in the prenatal diagnosis of overgrowth syndromes N Vora, DW Bianchi Prenatal Diagnosis: Published in Affiliation With the International Society …, 2009 | 78 | 2009 |
| Maternal obesity affects fetal neurodevelopmental and metabolic gene expression: a pilot study AG Edlow, NL Vora, L Hui, HC Wick, JM Cowan, DW Bianchi PloS one 9 (2), e88661, 2014 | 70 | 2014 |
| Cell-free DNA screening: complexities and challenges of clinical implementation MR Grace, E Hardisty, SK Dotters-Katz, NL Vora, JA Kuller Obstetrical & gynecological survey 71 (8), 477-487, 2016 | 68 | 2016 |
| An approach to integrating exome sequencing for fetal structural anomalies into clinical practice NL Vora, K Gilmore, A Brandt, C Gustafson, N Strande, L Ramkissoon, ... Genetics in Medicine 22 (5), 954-961, 2020 | 64 | 2020 |
| International Society for Prenatal Diagnosis Position Statement: cell free (cf) DNA screening for Down syndrome in multiple pregnancies GE Palomaki, RWK Chiu, MD Pertile, EA Sistermans, Y Yaron, ... Prenatal diagnosis 41 (10), 1222-1232, 2020 | 59 | 2020 |
| Prenatal genetic considerations of congenital anomalies of the kidney and urinary tract (CAKUT) AN Talati, CM Webster, NL Vora Prenatal diagnosis 39 (9), 679-692, 2019 | 58 | 2019 |
| An age-based framework for evaluating genome-scale sequencing results in newborn screening LV Milko, JM O'Daniel, DM DeCristo, SB Crowley, AKM Foreman, ... The Journal of pediatrics 209, 68-76, 2019 | 58 | 2019 |
| Fetal phenotypes emerge as genetic technologies become robust KJ Gray, LE Wilkins‐Haug, NJ Herrig, NL Vora Prenatal diagnosis 39 (9), 811-817, 2019 | 44 | 2019 |
| Maternal malignancy evaluation after discordant cell-free DNA results LM Carlson, E Hardisty, CC Coombs, NL Vora Obstetrics & Gynecology 131 (3), 464-468, 2018 | 43 | 2018 |
